Hematology

Idiopathic Hypereosinophilic Syndrome: A Clinical Case

A clinical case of idiopathic hypereosinophilic syndrome: diagnostic criteria, bone marrow examination, and mepolizumab therapy.

Blood smear, bone marrow aspirate, and eosinophil level graph during therapy
Blood smear, bone marrow aspirate, and eosinophil level graph during therapy

Clinical case: hypereosinophilia in a patient with a long history

Medical history: A 71-year-old woman with hypereosinophilia (absolute eosinophil count — AEC > 1.5 × 10⁹/L) for 10 years. Initially, she complained of vomiting, diarrhea, and an eczematous rash. Endoscopy revealed gastritis with mild eosinophilic infiltration. Later, asthma developed.

Diagnosis:

  • Secondary causes (parasites, allergies, autoimmune diseases) were excluded.
  • Bone marrow: eosinophilia (35%), without signs of malignancy.
  • Molecular tests (FISH for PDGFRA/B, TCR) — negative.
  • Diagnosis: idiopathic hypereosinophilic syndrome (HES).

Treatment:

  • Corticosteroids provided temporary relief, but relapse occurred upon dose reduction.
  • The monoclonal antibody mepolizumab (anti-IL-5) led to sustained normalization of AEC and resolution of symptoms.

Key points:

  1. HES is a diagnosis of exclusion. It is important to rule out secondary and clonal causes.
  2. Main affected organs: skin, GI tract, lungs, heart (risk of fibrosis and thromboembolism).
  3. In addition to corticosteroids, targeted therapy (anti-IL-5) is effective.